Pluripharm acquisition approved
The purchase by Abacus Medicine of all shares in the Pluripharm Group has been completed successfully.
The deal was announced on 13 July 2020, and has now received the expected approval of the competition authorities of the Netherlands (Autoriteit Consument en Markt) and Germany (Bundeskartellamt).
The deal will allow Pluripharm to expand its offering to independent pharmacies and hospitals in the Netherlands, and ensure a high availability of medicine.
Pluripharm has 170 employees and will continue to operate under its current name.